
Study Locations
If you think your child is eligible for the study, take the next step.
See if your child qualifies:
More information is also available at: clinicaltrials.gov, identifier NCT04895215.
Find a study location near you
All travel and other expenses for this study will be reimbursed.

UNITED STATES
ARIZONA
University of Arizona
Department of Pediatrics
PO Box 210158,
Room 510, Tucson, Arizona
85721
+1 520-626-1994
Southwestern Autism Research and Resource Center
2225 N 16th St, Phoenix, Arizona, 85006
+1 602-340-8717
CALIFORNIA
Cortica Marin
4000 Civic Center Drive, Ste 100, San Rafael, California 94903
+1 707-595-7174 ext 2233
Langley Porter Psychiatric Institute
401 Parnassus Ave, San Francisco, California, 94122
+1 415-476-7000
Cortica Westlake Village
2625 Townsgate Rd, Westlake Village, California, 91361
+1 707-582-5406
CONNECTICUT
Yale University, Child Study Center
230 S Frontage Rd, New Haven, Connecticut, 06510
+1 203-688-5997
FLORIDA
CNS Solutions, Inc.
5200 Belfort Rd, Ste 420, Jacksonville, Florida, 32256 420
+1 904-281-5757
CNS Solutions, Inc.
618 E South St, Orlando, Florida, 32801
+1 407-425-5100
Contact: Brad Littlejohn, MA, LMHC, CCRC
University of South Florida
3515 E Fletcher Ave, Tampa, Florida, 33613
+1 813-821-8032
ILLINOIS
AMR-Baber Research, Inc.
1460 Bond St, Naperville, Illinois, 60563
+1 630-272-4844
LOUISIANA
LSU Health - Shreveport
1801 Fairfield Ave, Shreveport, Louisiana, 71101
+1 318-429-2458
MASSACHUSETTS
Massachusetts General Hospital, Lurie Center
1 Maguire Road, Lexington, Massachusetts, 02421
+1 781-860-1700
NEVADA
Clinical Research of Southern Nevada, LLC.
7351 Prairie Falcon Rd, Ste 160, Las Vegas, Nevada, 89128
+1 702-838-0742
NEW YORK
Nathan S. Kline Institute for Psychiatric Research
140 Old Orangeburg Rd, Orangeburg, New York, 10962
+1 845-398-2184
Spectrum Neuroscience and Treatment Institute
901 5th Avenue, New York, NY 10021
+1 646-351-0220
OHIO
Ohio State University, Nisonger Center
1581 Dodd Dr, Columbus, Ohio, 43210
+1 614-336-1715
VIRIGINIA
Carilion Medical Center
2017 S Jefferson St, Roanoke, Virginia, 24014
+1 540-981-8025

AUSTRALIA
Queensland Children's Hospital
Centre for Clinical Trials in Rare Neurodevelopmental Disorders (CCTRND)
62 Graham St, South Brisbane, Brisbane, Queensland, 4101
+61 (0)7 3069 7532
The Children's Hospital at Westmead
Corner Hawkesbury Road and Hainsworth St, Westmead NSW 2145
+61 (0)2 9114 4189 (ext# 44189)
The Royal Children's Hospital
50 Flemington Rd, Parkville, Melbourne, Victoria, 3052
+61 (0)3 9936 6756
+61 (0)4 1174 5352
NEW ZEALAND
Optimal Clinical Trials,
Level 2/97 Grafton Road, Grafton, Auckland 1010, New Zealand
+64 (0)9 303 4987
“The lack of safe and effective treatment options for co-occurring conditions associated with ASD, such as irritability and anxiety, exacerbate the daily challenges faced by children and their families. I am encouraged by previous studies of AB-2004 and I look forward to assessing its potential as a safe alternative to atypical antipsychotics currently used to treat irritability associated with autism.”
-Robert L. Hendren, D.O., professor, psychiatry, Weill Institute for Neurosciences at the University of California, San Francisco, School of Medicine, and a principal investigator for the AB-2004 Phase 2 trial
